Actionable news
All posts from Actionable news
Actionable news in AZN: ASTRAZENECA PLC,

AstraZeneca (AZN) Earnings Report: Q3 2015 Conference Call Transcript


The following AstraZeneca (AZN - Get Report) conference call took place on November 5, 2015, 07:00 AM ET. This is a transcript of that earnings call:

Company Participants

  • Pascal Soriot; AstraZeneca; Executive Director, CEO
  • Luke Miels; AstraZeneca; EVP, GPPS, Global Medical Affairs, and Corporate Affairs
  • Marc Dunoyer; AstraZeneca; CFO
  • Sean Bohen; AstraZeneca; EVP, Global Medicines Development & Chief Medical Officer
  • Elisabeth Bjork; AstraZeneca; VP, Head of Cardiovascular & Metabolic Diseases
  • Mondher Mahjoubi; AstraZeneca; SVP, Global Product Strategy, Oncology

Other Participants

  • James Gordon; JPMorgan; Analyst
  • Jo Walton; Credit Suisse; Analyst
  • Tim Anderson; Sanford C. Bernstein; Analyst
  • Nicolas Guyon; Morgan Stanley; Analyst
  • Richard Parkes; Deutsche Bank; Analyst
  • Simon Baker; Exane BNP Paribas; Analyst
  • Mark Purcell; Barclays; Analyst

MANAGEMENT DISCUSSION SECTION Operator: Good afternoon. Welcome, ladies and gentlemen, to AstraZeneca's Q3 results analyst's conference.


Before I hand over to Pascal Soriot, I'd like to read the Safe Harbor statement. The Company intends to utilize the Safe Harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca . Although we believe our expectations are based on...